BioVaxys Technology Corp. C.BIOV

BIOV: RETAINS MAXIM GROUP AS FINANCIAL ADVISOR & INV BANKER

[Humanist]

(I think this is a good NR, SOMETHINGS IS BREWING) 

BIOVAXYS RETAINS MAXIM GROUP AS FINANCIAL ADVISOR AND INVESTMENT BANKER

by @newswire on 17 Apr 2023, 08:00

VANCOUVER, British Columbia, April 17, 2023 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") is pleased to announce that it has retained New York City-based Maxim Group LLC ("Maxim") as its financial advisor and investment banker to provide general financial advisory and investment banking services, including strategic planning, assessment of potential strategic alliances and capital requirements, and advising the Company with respect to the process of obtaining a listing on a US national stock exchange.

In consideration of its engagement and for past services rendered by Maxim, BioVaxys has agreed to issue Maxim 2,902,236 common shares, subject to the approval of the Canadian Securities Exchange. Any common shares issued to Maxim will be subject to a statutory restriction period of four months + one day.

James Passin, CEO of BioVaxys, stated, "We look forward to working with Maxim Group to enhance shareholder value and unlock potential transformative capital market opportunities."

About Maxim Group LLC
Founded in 2002, Maxim Group is a leading full-service investment bank, securities and wealth management firm headquartered in mid-town Manhattan providing a comprehensive array of financial services including investment banking, global institutional sales, equity research, fixed income and derivative sales & trading, merchant capital, private wealth management, and prime brokerage services to a diverse range of corporate clients, institutional investors and high-net-worth individuals. Maxim Group is a registered broker-dealer with the U.S. Securities and Exchange Commission and the Municipal Securities Rulemaking Board (MSRB).